Editorial - Counter culture
19 Sep 2005
While many market participants have expressed significant doubt that New York Mercantile Exchange (Nymex)'s London venture can be a success, project chairman Roy Leighton is probably right to point to OTC clearing as a potential competitive edge for the new exchange. ClearPort has, to date, been one of the most successful venues for OTC clearing and it is certainly fair to say that if Nymex...
The rest of this article is for subscribers only. Would you like to take a free trial?
- Unlimited access
- Data & graph exports
- Daily data brief
- Weekly newsletter
- News & Analysis access
- Extensive data searches
- Access to archive
- Weekly newsletter